Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | URGN | AMGN | VRTX | REGN | GSK |
| Company | Urogen Pharma Ltd | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 13.61 | 302.01 | 444.74 | 969.14 | 44.64 |
| High | 13.84 | 305.90 | 456.91 | 980.92 | 45.01 |
| Low | 13.24 | 299.50 | 443.47 | 967.43 | 44.56 |
| Last | 13.30 | 305.85 | 455.34 | 980.16 | 44.77 |
| Change | -0.25 | +4.85 | +12.29 | +10.25 | +0.75 |
| % Change | -1.85% | +1.61% | +2.77% | +1.06% | +1.70% |
| Volume | 112,200 | 4,488,800 | 2,362,700 | 833,100 | 3,623,800 |
| 20-Day Average Volume | 308,895 | 2,952,420 | 1,214,565 | 389,650 | 3,483,590 |
| Previous Close | 13.55 | 301.00 | 443.05 | 969.91 | 44.02 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.31 | 308.10 | 434.29 | 974.68 | 44.69 |
| 20-Day Raw Stochastic | 62.94% | 38.21% | 96.35% | 75.03% | 58.00% |
| 20-Day Relative Strength | 46.17% | 56.64% | 66.97% | 57.30% | 58.19% |
| Weighted Alpha | -30.70 | +35.97 | +38.45 | +31.77 | +33.60 |
| Today's Opinion | 88% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 72% Sell | 72% Buy | 88% Buy | 72% Buy | 88% Buy |
| Last Month's Opinion | 40% Sell | 24% Sell | 8% Buy | 8% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.50% since 05/23/24 | -0.21% since 05/23/24 | +1.01% since 05/23/24 | -0.04% since 05/23/24 | -0.84% since 05/23/24 |
| Low | 12.67 on 05/24/24 | 295.49 on 05/30/24 | 435.57 on 05/30/24 | 952.30 on 05/30/24 | 43.89 on 05/30/24 |
| High | 13.84 on 05/31/24 | 307.50 on 05/24/24 | 457.66 on 05/24/24 | 995.41 on 05/24/24 | 45.45 on 05/24/24 |
| 1-Month | |||||
| %Chg | -3.76% since 04/30/24 | +11.65% since 04/30/24 | +15.92% since 04/30/24 | +10.05% since 04/30/24 | +8.04% since 04/30/24 |
| Low | 10.60 on 05/13/24 | 273.38 on 05/01/24 | 392.47 on 05/01/24 | 888.52 on 05/01/24 | 42.28 on 05/01/24 |
| High | 14.89 on 05/06/24 | 322.60 on 05/03/24 | 457.66 on 05/24/24 | 997.87 on 05/22/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | -27.44% since 02/29/24 | +11.69% since 02/29/24 | +8.22% since 02/29/24 | +1.46% since 02/29/24 | +6.85% since 02/29/24 |
| Low | 10.60 on 05/13/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 18.63 on 03/04/24 | 322.60 on 05/03/24 | 457.66 on 05/24/24 | 997.87 on 05/22/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +3.58% since 11/29/23 | +14.72% since 11/29/23 | +29.73% since 11/29/23 | +21.22% since 11/29/23 | +26.15% since 11/29/23 |
| Low | 10.60 on 05/13/24 | 260.68 on 04/19/24 | 347.51 on 12/04/23 | 802.55 on 12/04/23 | 35.60 on 11/30/23 |
| High | 19.87 on 02/16/24 | 329.72 on 02/05/24 | 457.66 on 05/24/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 317,802 | 161,466,928 | 114,330,384 | 106,870,488 | 91,228,808 |
| Shares Outstanding, K | 23,454 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 82,710,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -102,240,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 18,780,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -32,290,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.09 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.97 on 05/13/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/13/24 | 05/02/24 | 05/06/24 | 05/02/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.91 | 29.29 | 26.04 | 10.96 |